ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Fractyl Health Inc

Fractyl Health Inc (GUTS)

2.065
0.005
( 0.24% )
Updated: 10:11:56

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.065
Bid
2.06
Ask
2.07
Volume
33,807
2.05 Day's Range 2.19
1.74 52 Week Range 14.50
Market Cap
Previous Close
2.06
Open
2.07
Last Trade
100
@
2.065
Last Trade Time
10:11:56
Financial Volume
$ 70,747
VWAP
2.0927
Average Volume (3m)
363,653
Shares Outstanding
2,095,000
Dividend Yield
-
PE Ratio
-0.05
Earnings Per Share (EPS)
-45
Revenue
120k
Net Profit
-94.27M

About Fractyl Health Inc

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Fractyl Health Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker GUTS. The last closing price for Fractyl Health was $2.06. Over the last year, Fractyl Health shares have traded in a share price range of $ 1.74 to $ 14.50.

Fractyl Health currently has 2,095,000 shares outstanding. The market capitalization of Fractyl Health is $4.32 million. Fractyl Health has a price to earnings ratio (PE ratio) of -0.05.

GUTS Latest News

Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates

REMAIN-1 weight maintenance pivotal study enrollment progressing rapidly; mid-point data analysis expected in Q2 2025 Anticipate reporting data from REVEAL-1 open-label cohort beginning in Q4...

Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024

13-week follow-up represents the longest data to-date demonstrating durable efficacy of RJVA-001 on weight and blood sugar in the diet-induced obesity (DIO) mouse model Company plans to use...

Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024

Single Revita procedure led to sustained, clinically meaningful weight loss in majority of patients with Type 2 Diabetes REMAIN-1 weight maintenance pivotal study on-track to report mid-point data...

Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024

BURLINGTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root...

Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024

BURLINGTON, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root...

Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference

BURLINGTON, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root...

Fractyl Health to Participate in Upcoming September Investor Conferences

BURLINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.285-12.12765957452.352.381.913682672.07334816CS
4-0.395-16.05691056912.463.4811.914829042.6149749CS
12-1.345-39.44281524933.413.721.913636532.70170267CS
26-4.835-70.07246376816.97.891.743171893.15862901CS
52-11.685-84.981818181813.7514.51.743199345.05580548CS
156-11.685-84.981818181813.7514.51.743199345.05580548CS
260-11.685-84.981818181813.7514.51.743199345.05580548CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SKKSKK Holdings Limited
$ 10.86
(138.16%)
2.68M
WORXSCWorx Corporation
$ 2.15
(119.39%)
80.83M
CRNCCerence Inc
$ 4.50
(59.57%)
7.99M
SPAISafe Pro Group Inc
$ 4.3999
(37.50%)
34M
CDTConduit Pharmaceuticals Inc
$ 0.1243
(34.67%)
405.44M
PYXSPyxis Oncology Inc
$ 2.0101
(-47.38%)
6.59M
KURAKura Oncology Inc
$ 10.02
(-37.02%)
5.21M
BLRXBioLineRx Ltd
$ 0.3805
(-30.21%)
4.32M
AGFYAgrify Corporation
$ 27.2093
(-29.80%)
260.84k
SHOTWSafety Shot Inc
$ 0.11
(-26.67%)
1,000
CDTConduit Pharmaceuticals Inc
$ 0.1243
(34.67%)
405.44M
AKTSAkoustis Technologies Inc
$ 0.0995
(14.24%)
160.04M
NVDANVIDIA Corporation
$ 144.33
(-1.07%)
126.36M
WORXSCWorx Corporation
$ 2.15
(119.39%)
80.83M
ELABElevai Labs Inc
$ 0.02015
(-5.84%)
60.3M